174 related articles for article (PubMed ID: 29302844)
1. Cost-Utility of Access to Care, a National HIV Linkage, Re-engagement and Retention in Care Program.
Maulsby C; Jain KM; Weir BW; Enobun B; Werner M; Riordan M; Holtgrave DR;
AIDS Behav; 2018 Nov; 22(11):3734-3741. PubMed ID: 29302844
[TBL] [Abstract][Full Text] [Related]
2. Cost-Utility Analysis of Three U.S. HIV Linkage and Re-engagement in Care Programs from Positive Charge.
Jain KM; Zulliger R; Maulsby C; Kim JJ; ; Charles V; Riordan M; Holtgrave D
AIDS Behav; 2016 May; 20(5):973-6. PubMed ID: 26563760
[TBL] [Abstract][Full Text] [Related]
3. Cost and threshold analysis of positive charge, a multi-site linkage to HIV care program in the United States.
Kim JJ; Maulsby C; Zulliger R; Jain K; ; Charles V; Riordan M; Davey-Rothwell M; Holtgrave DR
AIDS Behav; 2015 Oct; 19(10):1735-41. PubMed ID: 26139421
[TBL] [Abstract][Full Text] [Related]
4. The Cost and Threshold Analysis of Retention in Care (RiC): A Multi-Site National HIV Care Program.
Maulsby C; Jain KM; Weir BW; Enobun B; Riordan M; Charles VE; ; Holtgrave DR
AIDS Behav; 2017 Mar; 21(3):643-649. PubMed ID: 27873083
[TBL] [Abstract][Full Text] [Related]
5. Cost analysis of enhancing linkages to HIV care following jail: a cost-effective intervention.
Spaulding AC; Pinkerton SD; Superak H; Cunningham MJ; Resch S; Jordan AO; Yang Z
AIDS Behav; 2013 Oct; 17 Suppl 2(0 2):S220-6. PubMed ID: 23138877
[TBL] [Abstract][Full Text] [Related]
6. Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive.
Gray RT; Watson J; Cogle AJ; Smith DE; Hoy JF; Bastian LA; Finlayson R; Drummond FM; Whittaker B; Law MG; Petoumenos K
Sex Health; 2018 Feb; 15(1):13-19. PubMed ID: 28874236
[TBL] [Abstract][Full Text] [Related]
7. A Mixed-Methods Exploration of the Needs of People Living with HIV (PLWH) Enrolled in Access to Care, a National HIV Linkage, Retention and Re-Engagement in Medical Care Program.
Maulsby C; Enobun B; Batey DS; Jain KM; ; Riordan M; Werner M; Holtgrave DR
AIDS Behav; 2018 Mar; 22(3):819-828. PubMed ID: 28550379
[TBL] [Abstract][Full Text] [Related]
8. Cost and cost threshold analyses for 12 innovative US HIV linkage and retention in care programs.
Jain KM; Maulsby C; Brantley M; ; Kim JJ; Zulliger R; Riordan M; Charles V; Holtgrave DR
AIDS Care; 2016 Sep; 28(9):1199-204. PubMed ID: 27017972
[TBL] [Abstract][Full Text] [Related]
9. Understanding the variation in costs among HIV primary care providers.
Gilman BH; Green JC
AIDS Care; 2008 Oct; 20(9):1050-6. PubMed ID: 18825514
[TBL] [Abstract][Full Text] [Related]
10. Barriers and Facilitators to the Implementation of a National HIV Linkage, Re-Engagement, and Retention in Care Program.
Maulsby C; Sacamano P; Jain KM; Enobun B; Brantley ML; Kim HY; Riordan M; Werner M; ; Holtgrave DR
AIDS Educ Prev; 2017 Oct; 29(5):443-456. PubMed ID: 29068718
[TBL] [Abstract][Full Text] [Related]
11. The Epidemiologic and Economic Impact of Improving HIV Testing, Linkage, and Retention in Care in the United States.
Shah M; Risher K; Berry SA; Dowdy DW
Clin Infect Dis; 2016 Jan; 62(2):220-229. PubMed ID: 26362321
[TBL] [Abstract][Full Text] [Related]
12. Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.
Luong Nguyen LB; Yazdanpanah Y; Maman D; Wanjala S; Vandenbulcke A; Price J; Parker RA; Hennequin W; Mendiharat P; Freedberg KA
Clin Infect Dis; 2018 Aug; 67(5):719-726. PubMed ID: 29746619
[TBL] [Abstract][Full Text] [Related]
13. The Cost and Cost-utility of Three Public Health HIV Case-finding Strategies: Evidence from Rhode Island, 2012-2014.
Li XC; Kusi L; Marak T; Bertrand T; Chan PA; Galárraga O
AIDS Behav; 2018 Nov; 22(11):3726-3733. PubMed ID: 29079947
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
Pinkerton SD; Holtgrave DR; Pinkerton HJ
Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
[TBL] [Abstract][Full Text] [Related]
15. The economics of effective AIDS treatment in Thailand.
Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
[TBL] [Abstract][Full Text] [Related]
16. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
[TBL] [Abstract][Full Text] [Related]
17. Adherence clubs for long-term provision of antiretroviral therapy: cost-effectiveness and access analysis from Khayelitsha, South Africa.
Bango F; Ashmore J; Wilkinson L; van Cutsem G; Cleary S
Trop Med Int Health; 2016 Sep; 21(9):1115-23. PubMed ID: 27300077
[TBL] [Abstract][Full Text] [Related]
18. HIV/AIDS. Universal access in the fight against HIV/AIDS.
Girard F; Ford N; Montaner J; Cahn P; Katabira E
Science; 2010 Jul; 329(5988):147-9. PubMed ID: 20616254
[No Abstract] [Full Text] [Related]
19. Providing antiretroviral therapy for HIV infection.
Steinbrook R
N Engl J Med; 2001 Mar; 344(11):844-6. PubMed ID: 11248164
[No Abstract] [Full Text] [Related]
20. The cost effectiveness of combination antiretroviral therapy for HIV disease.
Freedberg KA; Losina E; Weinstein MC; Paltiel AD; Cohen CJ; Seage GR; Craven DE; Zhang H; Kimmel AD; Goldie SJ
N Engl J Med; 2001 Mar; 344(11):824-31. PubMed ID: 11248160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
